Hcv antiviral and cytotoxicity drug screening assay

C - Chemistry – Metallurgy – 12 – Q

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12Q 1/70 (2006.01) G01N 33/567 (2006.01)

Patent

CA 2481502

The present invention relates to a cell-based HTS assay for evaluation of antiviral activity of compounds against HCV using HCV replicon.

La présente invention concerne un dosage HTS à base cellulaire pour évaluer l'activité antivirale de composés contre le virus de l'hépatite C par utilisation d'un réplicon du virus de l'hépatite C.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hcv antiviral and cytotoxicity drug screening assay does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hcv antiviral and cytotoxicity drug screening assay, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hcv antiviral and cytotoxicity drug screening assay will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1909102

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.